Old Web
English
Sign In
Acemap
>
authorDetail
>
Karin Purshouse
Karin Purshouse
University of Oxford
Pembrolizumab
Bladder cancer
Medicine
Tolerability
Urology
4
Papers
117
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I study to assess the safety and tolerability of intravesical pembrolizumab in recurrent non-muscle invasive bladder cancer (NMIBC)
2019
European Urology Supplements
Karin Purshouse
Victoria K Woodcock
C Butcher
C. Haddon
G. Verrall
L Elhussein
Mariolina Salio
Mark R. Middleton
Vincenzo Cerundolo
J. Kwok
Sarah P. Blagden
Andrew Protheroe
Jeremy Crew
Show All
Source
Cite
Save
Citations (1)
A phase I study to assess the safety and tolerability of intravesical pembrolizumab in recurrent non-muscle invasive bladder cancer (NMIBC).
2019
Journal of Clinical Oncology
Victoria K Woodcock
Karin Purshouse
Chrissie Butcher
Caroline Haddon
Gillian Verrall
Leena Elhussein
Mariolina Salio
Mark R. Middleton
Vincenzo Cerundolo
Jeremy Crew
Andrew Protheroe
Show All
Source
Cite
Save
Citations (4)
Challenges to DNA replication in hypoxic conditions
2018
FEBS Journal
Natalie Ng
Karin Purshouse
Iosifina P. Foskolou
Monica M. Olcina
Ester M. Hammond
Show All
Source
Cite
Save
Citations (26)
The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer.
2017
Oncogene
L L da Motta
Ioanna Ledaki
Karin Purshouse
Shozeb Haider
M A De Bastiani
Dilair Baban
Matteo Morotti
Graham Steers
Simon Wigfield
Esther Bridges
J-L Li
Stefan Knapp
Daniel Ebner
Fábio Klamt
Adrian L. Harris
Alan McIntyre
Show All
Source
Cite
Save
Citations (86)
1